Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IMPROVE-2
PACTR202005916875055Phase 3Completed
- Sponsor
- Liverpool School of Tropical Medicine
- Start
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of trimethoprim + sulfamethoxazole and dihydroartemisinin + piperaquine in malaria (2 arms), sponsored by Liverpool School of Tropical Medicine. Primary endpoint: Cumulative incidence of malaria infection. Started Jun 2019; status: completed.
02
Drugs
trimethoprim + sulfamethoxazoledihydroartemisinin + piperaquine
03
Conditions
malaria
Beyond the preview
Go deeper on PACTR202005916875055.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202005916875055.